Elimination of blood group antigens: Hope and reality

British Journal of Haematology

Volumn 152, Issue 4, 2011, Pages 392-400

  Bagnis, Claude ^a   Chiaroni, Jacques ^a   Bailly, Pascal ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Blood group systems; Enzyme converted group O red blood cell; Genetic manipulation; Polyethylene glycol; Stem cell

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; BLOOD GROUP O ANTIGEN; CD34 ANTIGEN; COMPLEMENTARY DNA; LENTIVIRUS VECTOR; MACROGOL; MACROGOL DERIVATIVE; NUCLEIC ACID; PEPTIDE DERIVATIVE; POLYPEPTIDE; RETROVIRUS VECTOR; SHORT HAIRPIN RNA;

ANTIGEN ANTIBODY REACTION; ANTIGENICITY; BLOOD COMPATIBILITY; BLOOD DONOR; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION REACTION; DISSEMINATED INTRAVASCULAR CLOTTING; EMBRYONIC STEM CELL; ERYTHROCYTE TRANSFUSION; GENE THERAPY; GENETIC ENGINEERING; HEMAGGLUTINATION TEST; HEMATOPOIETIC STEM CELL; HEMOGLOBINURIA; HEMOLYSIS; HUMAN; IMMUNOGENICITY; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RECIPIENT; REVIEW; RNA INTERFERENCE; VIRAL GENE DELIVERY SYSTEM;

BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; GENETIC ENGINEERING; HISTOCOMPATIBILITY; HUMANS; POLYETHYLENE GLYCOLS;

EID: 78851469529     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08561.x     Document Type: Review

References (71)

1. Armstrong, J.K., Leger, R., Wenby, R.B., Meiselman, H.J, Garratty, G. & Fisher, T. (2003) Occurrence of an antibody to poly(ethylene gycol) in normal donors. Blood, 102, 556A.
2. Armstrong, J.K., Hempel, G., Koling, S., Chan, L.S., Fisher, T., Meiselman, H.J. & Garratty, G. (2007) Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients. Cancer, 110, 103-111.
3. Bagnis, C., Chapel, S., Chiaroni, J. & Bailly, P. (2009a) A genetic strategy to control expression of human blood group antigens in red blood cells generated in vitro. Transfusion, 49, 967-976.
4. Bagnis, C., Bailly, P. & Chapel-Fernandes, S. (2009b) Using an EGFPmeter to evaluate the lentiviral vector production: tricks and traps. Methods in Molecular Biology, 515, 151-163.
5. Blackall, D.P., Armstrong, J.K., Meiselman, H.J. & Fisher, T.C. (2001) Polyethylene glycol-coated red blood cells fail to bind glycophorin A-specific antibodies and are impervious to invasion by the Plasmodium falciparum malaria parasite. Blood, 97, 551-556.
6. Bonig, H., Chang, K.H., Geisen, C., Seifried, E. & Ware, C. (2008) Blood types of current embryonic stem cell lines are not conducive to culturing 'universal-donor' red blood cells. Transfusion, 48, 1039-1040.
7. Bradley, A.J. & Scott, M.D. (2007) Immune complex binding by immunocamouflaged [poly(ethylene glycol)-grafted] erythrocytes. American Journal of Hematology, 82, 970-975.
8. Bradley, A.J., Test, S.T., Murad, K.L., Mitsuyoshi, J. & Scott, M.D. (2001) Interactions of IgM ABO antibodies and complement with methoxy-PEG-modified human RBCs. Transfusion, 41, 1225-1233.
9. Bradley, A.J., Murad, K.L., Regan, K.L. & Scott, M.D. (2002) Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes: size does matter. Biochimica et Biophysica Acta, 1561, 147-158.
10. Chang, A.H. & Sadelain, M. (2007) The genetic engineering of hematopoietic stem cells: the rise of lentiviral vectors, the conundrum of the ltr, and the promise of lineage-restricted vectors. Molecular Therapy, 15, 445-456.
11. Chen, A.M. & Scott, M.D. (2001) Current and future applications of immunological attenuation via pegylation of cells and tissue. BioDrugs, 15, 833-847.
12. Cockrell, A.S. & Kafri, T. (2007) Gene delivery by lentivirus vectors. Molecular Biotechnology, 36, 184-204.
13. Cullen, B.R. (2006) Induction of stable RNA interference in mammalian cells. Gene Therapy, 13, 503-508.
14. Efroni, S., Duttagupta, R., Cheng, J., Dehghani, H., Hoeppner, D.J., Dash, C., Bazett-Jones, D.P., Le Grice, S., McKay, R.D., Buetow, K.H., Gingeras, T.R., Misteli, T. & Meshorer, E. (2008) Global transcription in pluripotent embryonic stem cells. Cell Stem Cell, 2, 437-447.
15. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E. & Mello, C.C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806-811.
16. Garratty, G. (2004) Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs. Transfusion Medicine Reviews, 18, 245-256.
17. Garratty, G. (2008) Modulating the red cell membrane to produce universal/stealth donor red cells suitable for transfusion. Vox Sanguinis, 94, 87-95.
18. Giarratana, M.C., Kobari, L., Lapillonne, H., Chalmers, D., Kiger, L., Cynober, T., Marden, M.C., Wajcman, H. & Douay, L. (2005) Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nature Biotechnology, 23, 69-74.
19. Goldstein, J. (1989) Conversion of ABO blood groups. Transfusion Medicine Reviews, 3, 206-212.
20. Goldstein, J., Siviglia, G., Hurst, R., Lenny, L. & Reich, L. (1982) Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals. Science, 215, 168-170.
21. Gundersen, S.I., Kennedy, M.S. & Palmer, A.F. (2008) Immune recognition of exposed xenoantigens on the surface of PEGylated bovine red blood cells. Biotechnology and Bioengineering, 101, 337-344.
22. Hacein-Bey-Abina, S., Garrigue, A., Wang, G.P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., Asnafi, V., MacIntyre, E., Dal Cortivo, L., Radford, I., Brousse, N., Sigaux, F., Moshous, D., Hauer, J., Borkhardt, A., Belohradsky, B.H., Wintergerst, U., Velez, M.C., Leiva, L., Sorensen, R., Wulffraat, N., Blanche, S., Bushman, F.D., Fischer, A. & Cavazzana-Calvo, M. (2008) Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. Journal of Clinical Investigation, 118, 3132-3142.
23. Harpaz, N., Flowers, H.M. & Sharon, N. (1974) Purification of coffee bean alpha-galactosidase by affinity chromatography. Biochimica et Biophysica Acta, 341, 213-221.
24. Hashemi-Najafabadi, S., Vasheghani-Farahani, E., Shojaosadati, S.A., Rasaee, M.J., Armstrong, J.K., Moin, M. & Pourpak, Z. (2006) A method to optimize PEG-coating of red blood cells. Bioconjugate Chemistry, 17, 1288-1293.
25. Hermand, P., Gane, P., Mattei, M.G., Sistonen, P., Cartron, J.P. & Bailly, P. (1995) Molecular basis and expression of the LWa/LWb blood group polymorphism. Blood, 86, 1590-1594.
26. Jeong, S.T. & Byun, S.M. (1996) Decreased agglutinability of methoxy-polyethylene glycol attached red blood cells: significance as a blood substitute. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 24, 503-511.
27. Jinek, M. & Doudna, J.A. (2009) A three-dimensional view of the molecular machinery of RNA interference. Nature, 457, 405-412.
28. Jones, M.C., Propper, D.J., Weber, B.K., Stewart, K.N., Catto, G.R. & Cunningham, C. (1991) Reduction of sensitization induced by blood transfusion in the rat by monoclonal antibodies. Transplantation, 51, 681-685.
29. Jovtchev, S., Stoeff, S., Arnold, K. & Zschornig, O. (2008) Studies on the aggregation behaviour of pegylated human red blood cells with the Zeta sedimentation technique. Clinical Hemorheology and Microcirculation, 39, 229-233.
30. Kizhakkedathu, J.N., Janzen, J., Le, Y., Kainthan, R.K. & Brooks, D.E. (2009) Poly[oligo(ethylene glycol)acrylamide] brushes by surface initiated polymerization: effect of macromonomer chain length on brush growth and protein adsorption from blood plasma. Langmuir, 9, 3794-3801.
31. Kobayashi, T., Liu, D., Ogawa, H., Miwa, Y., Nagasaka, T., Maruyama, S., Li, Y.T., Onishi, A., Kuzuya, T., Kadomatsu, K., Uchida, K. & Nakao, A. (2007) Alternative strategy for overcoming ABO incompatibility. Transplantation, 83, 1284-1286.
32. Kobayashi, T., Liu, D., Ogawa, H., Miwa, Y., Nagasaka, T., Maruyama, S., Li, Y.T., Onishi, A., Iwamoto, M., Kuzuya, T., Kadomatsu, K., Uchida, K. & Nakao, A. (2009) Removal of blood group A/B antigen in organs by ex vivo and in vivo administration of endo-beta-galactosidase (ABase) for ABO-incompatible transplantation. Transplant Immunology, 20, 132-138.
33. Kondo, M., Wagers, A.J., Manz, M.G., Prohaska, S.S., Scherer, D.C., Beilhack, G.F., Shizuru, J.A. & Weissman, I.L. (2003) Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annual Review of Immunology, 21, 759-806.
34. Kruskall, M.S., AuBuchon, J.P., Anthony, K.Y., Herschel, L., Pickard, C., Biehl, R., Horowitz, M., Brambilla, D.J. & Popovsky, M.A. (2000) Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O. Transfusion, 40, 1290-1298.
35. Lenny, L.L., Hurst, R., Goldstein, J., Benjamin, L.J. & Jones, R.L. (1991) Single-unit transfusions of RBC enzymatically converted from group B to group O to A and O normal volunteers. Blood, 77, 1383-1388.
36. Lenny, L.L., Hurst, R., Zhu, A., Goldstein, J. & Galbraith, R.A. (1995) Multiple-unit and second transfusions of red cells enzymatically converted from group B to group O: report on the end of phase 1 trials. Transfusion, 35, 899-902.
37. Lensch, M.W., Schlaeger, T.M., Zon, L.I. & Daley, G.Q. (2007) Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera. Cell Stem Cell, 1, 253-258.
38. Li, M. & Rossi, J.J. (2008) Lentiviral vector delivery of siRNA and shRNA encoding genes into cultured and primary hematopoietic cells. Methods in Molecular Biology, 433, 287-299.
39. Liu, W., Smythe, J.S., Scott, M.L., Jones, J.W., Voak, D. & Avent, N.D. (1999) Site-directed mutagenesis of the human D antigen: definition of D epitopes on the sixth external domain of the D protein expressed on K562 cells. Transfusion, 39, 17-25.
40. Liu, Q.P., Sulzenbacher, G., Yuan, H., Bennett, E.P., Pietz, G., Saunders, K., Spence, J., Nudelman, E., Levery, S.B., White, T., Neveu, J.M., Lane, W.S., Bourne, Y., Olsson, M.L., Henrissat, B. & Clausen, H. (2007) Bacterial glycosidases for the production of universal red blood cells. Nature Biotechnology, 25, 454-464.
41. Liu, Q.P., Yuan, H., Bennett, E.P., Levery, S.B., Nudelman, E., Spence, J., Pietz, G., Saunders, K., White, T., Olsson, M.L., Henrissat, B., Sulzenbacher, G. & Clausen, H. (2008) Identification of a GH110 subfamily of alpha 1, 3-galactosidases: novel enzymes for removal of the alpha 3Gal xenotransplantation antigen. The Journal of Biological Chemistry, 283, 8545-8554.
42. Loh, Y.H., Agarwal, S., Park, I.H., Urbach, A., Huo, H., Heffner, G.C., Kim, K., Miller, J.D., Ng, K. & Daley, G.Q. (2009) Generation of induced pluripotent stem cells from human blood. Blood, 113, 5476-5479.
43. Lu, S.J., Feng, Q., Park, J.S., Vida, L., Lee, B.S., Strausbauch, M., Wettstein, P.J., Honig, G.R. & Lanza, R. (2008) Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood, 112, 4475-4484.
44. Lublin, D.M. (2000) Universal RBCs. Transfusion, 40, 1285-1289.
45. Lucien, N., Sidoux-Walter, F., Roudier, N., Ripoche, P., Huet, M., Trinh-Trang-Tan, M.M., Cartron, J.P. & Bailly, P. (2002) Antigenic and functional properties of the human red blood cell urea transporter hUT-B1. The Journal of Biological Chemistry, 277, 34101-34108.
46. Maherali, N. & Hochedlinger, K. (2008) Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell, 3, 595-605.
47. Mohiuddin, M.M., Ogawa, H., Yin, D.P. & Galili, U. (2003a) Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells. Blood, 102, 229-236.
48. Mohiuddin, M.M., Ogawa, H., Yin, D.P., Shen, J. & Galili, U. (2003b) Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen. Transplantation, 75, 258-262.
49. Montano, R.F., Penichet, M.L., Blackall, D.P., Morrison, S.L. & Chintalacharuvu, K.R. (2009) Recombinant polymeric IgG anti-Rh: a novel strategy for development of direct agglutinating reagents. Journal of Immunological Methods, 340, 1-10.
50. Mountford, J.C. (2008) Human embryonic stem cells: origins, characteristics and potential for regenerative therapy. Transfusion Medicine, 18, 1-12.
51. Murad, K.L., Gosselin, E.J., Eaton, J.W. & Scott, M.D. (1999) Stealth cells: prevention of major histocompatibility complex class II-mediated T-cell activation by cell surface modification. Blood, 94, 2135-2141.
52. Nacharaju, P., Boctor, F.N., Manjula, B.N. & Acharya, S.A. (2005) Surface decoration of red blood cells with maleimidophenyl-polyethylene glycol facilitated by thiolation with iminothiolane: an approach to mask A, B, and D antigens to generate universal red blood cells. Transfusion, 45, 374-383.
53. Nacharaju, P., Manjula, B.N. & Acharya, S.A. (2007) Thiolation mediated pegylation platform to generate functional universal red blood cells. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 35, 107-118.
54. Nakajima, F., Tokunaga, K. & Nakatsuji, N. (2007) Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. Stem Cells, 25, 983-985.
55. Nakatsuji, N., Nakajima, F. & Tokunaga, K. (2008) HLA-haplotype banking and iPS cells. Nature Biotechnology, 26, 739-740.
56. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M. & Trono, D. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science, 272, 263-267.
57. Ogawa, H., Mohiuddin, M.M., Yin, D.P., Shen, J., Chong, A.S. & Galili, U. (2004) Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance. Transplantation, 77, 366-373.
58. Rajan, V.P., Larsen, R.D., Ajmera, S., Ernst, L.K. & Lowe, J.B. (1989) A cloned human DNA restriction fragment determines expression of a GDP-L-fucose: beta-D-galactoside 2-alpha-L-fucosyltransferase in transfected cells. Evidence for isolation and transfer of the human H blood group locus. The Journal of Biological Chemistry, 264, 11158-11167.
59. Rossi, J.J. (2008) Expression strategies for short hairpin RNA interference triggers. Human Gene Therapy, 19, 313-317.
60. Roudier, N., Ripoche, P., Gane, P., Le Pennec, P.Y., Daniels, G., Cartron, J.P. & Bailly, P. (2002) AQP3 deficiency in humans and the molecular basis of a novel blood group system, GIL. The Journal of Biological Chemistry, 277, 45854-45859.
61. Samakoglu, S., Lisowski, L., Budak-Alpdogan, T., Usachenko, Y., Acuto, S., Di Marzo, R., Maggio, A., Zhu, P., Tisdale, J.F., Riviere, I. & Sadelain, M. (2006) A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference. Nature Biotechnology, 24, 89-94.
62. Scott, M.D. & Murad, K.L. (1998) Cellular camouflage: fooling the immune system with polymers. Current Pharmaceutical Design, 4, 423-438.
63. Scott, M.D., Murad, K.L., Koumpouras, F., Talbot, M. & Eaton, J.W. (1997) Chemical camouflage of antigenic determinants: stealth erythrocytes. Proceedings of the National Academy of Sciences of the United States of America, 94, 7566-7571.
64. Seifinejad, A., Taei, A., Totonchi, M., Vazirinasab, H., Hassani, S.N., Aghdami, N., Shahbazi, E., Yazdi, R.S., Salekdeh, G.H. & Baharvand, H. (2010) Generation of human induced pluripotent stem cells from a Bombay individual: moving towards 'universal-donor' red blood cells. Biochemical and Biophysical Research Communications, 391, 329-334.
65. Shizuru, J.A., Negrin, R.S. & Weissman, I.L. (2005) Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annual Review of Medicine, 56, 509-538.
66. Sidoux-Walter, F., Lucien, N., Olives, B., Gobin, R., Rousselet, G., Kamsteeg, E.J., Ripoche, P., Deen, P.M., Cartron, J.P. & Bailly, P. (1999) At physiological expression levels the Kidd blood group/urea transporter protein is not a water channel. The Journal of Biological Chemistry, 274, 30228-30235.
67. Suyama, K., Li, H. & Zhu, A. (2000) Surface expression of Rh-associated glycoprotein (RhAG) in nonerythroid COS-1 cells. Blood, 95, 336-341.
68. Szabo, E., Rampalli, S., Risueno, R.M., Schnerch, A., Mitchell, R., Fiebig-Comyn, A., Levadoux-Martin, M. & Bhatia, M. (2010) Direct conversion of human fibroblasts to multilineage blood progenitors. Nature, 468, 521-526.
69. Takahashi, K. & Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
70. Yamamoto, F. & Hakomori, S. (1990) Sugar-nucleotide donor specificity of histo-blood group A and B transferases is based on amino acid substitutions. The Journal of Biological Chemistry, 265, 19257-19262.
71. Zhou, H., Wu, S., Joo, J.Y., Zhu, S., Han, D.W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., Siuzdak, G., Scholer, H.R., Duan, L. & Ding, S. (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4, 381-384.